In most cases of Alzheimer's diseased (AD), it is impossible to identity the triggering event which leads to the neurodegenerative process. However, in a small subset (2-3%) of familial Alzheimer disease (FAD) kindreds, several mutations have been found in a chromosome 21 gene, APP encoding the precursor of the Abeta peptide that is deposited in amyloid plaques. Detailed family studies have shown that AD is genetically heterogeneous and linkage studies using markers from other chromosomes have led to the localization of a late-onset (more 65 years) FAD locus mapping within or close to the APOE gene on chromosome 19. More recently, the extended FAD pedigree collections made possible through the efforts of the Massachusetts ADRC over the past ten years have allowed our laboratory in collaboration to localize a major FAD locus on chromosome 14. Among the FAD pedigrees screened in our Boston-Toronto study, six independent pedigrees individually yielded lod scores exceeding the conventional significance value of 3. The magnitude and robustness of these scores indicate definitively that there is a chromosome 14 locus that most likely accounts for a major proportion (70-90%) of early-onset FAD (lessor 65 years). The goal of this proposal is to employ a variety of strategies including positional cloning, physical mapping, and testing of candidate genes to ultimately isolate, identify, and characterize the FAD gene defect on chromosome 14. Given our extensive collection of well characterized early-onset FAD pedigrees and the large amount of preliminary data that we have already amassed concerning the chromosome 14 FAD locus, we are in a uniquely ideal position to successfully carry out the studies described in this application. The knowledge obtained from the proposed studies could provide critical clues to the causes of both inherited and sporadic AD, and ultimately provide vital information for designing treatments aimed at strategically intervening with the effects of discovered FAD gene defects.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG005134-11
Application #
3745726
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
11
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Wegmann, Susanne; Eftekharzadeh, Bahareh; Tepper, Katharina et al. (2018) Tau protein liquid-liquid phase separation can initiate tau aggregation. EMBO J 37:
Racine, Annie M; Brickhouse, Michael; Wolk, David A et al. (2018) The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment. Alzheimers Dement (Amst) 10:301-310
Bennett, Rachel E; Robbins, Ashley B; Hu, Miwei et al. (2018) Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease. Proc Natl Acad Sci U S A 115:E1289-E1298
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Kaur, Antarpreet; Edland, Steven D; Peavy, Guerry M (2018) The MoCA-Memory Index Score: An Efficient Alternative to Paragraph Recall for the Detection of Amnestic Mild Cognitive Impairment. Alzheimer Dis Assoc Disord 32:120-124
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Lee, Catherine; Betensky, Rebecca A; Alzheimer's Disease Neuroimaging Initiative (2018) Time-to-event data with time-varying biomarkers measured only at study entry, with applications to Alzheimer's disease. Stat Med 37:914-932
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416

Showing the most recent 10 out of 966 publications